Contents

Current Vascular Pharmacology, Volume 5 - Number 3

Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]

, 5(3): 173 - 174

Anna I. Kakafika, Dimitri P. Mikhailidis, Anthony S. Wierzbicki, Asterios Karagiannis and Vasilios G. Athyros


DOI: 10.2174/157016107781024145




Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments

, 5(3): 175 - 184

John C. Ashton and Paul F. Smith


DOI: 10.2174/157016107781024109




Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management

, 5(3): 185 - 194

Joachim R. Ehrlich, Stanley Nattel and Stefan H. Hohnloser


DOI: 10.2174/157016107781024073




Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease

, 5(3): 195 - 209

Dimitrios Mikroulis, Nikolaos Papanas, Efstratios Maltezos and Georgios Bougioukas


DOI: 10.2174/157016107781024136




New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation

, 5(3): 211 - 219

Matthias Hammwohner, Alessandra D'Alessandro, Oliver Wolfram and Andreas Goette


DOI: 10.2174/157016107781024118




Is There a True Beneficial Effect of Statin Therapy in the Acute Phase of Unstable Angina or Myocardial Infarction?

, 5(3): 221 - 225

Luis C.L. Correia


DOI: 10.2174/157016107781024127




Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness

, 5(3): 227 - 237

Polychronis Dilaveris, Georgios Giannopoulos, Maria Riga, Andreas Synetos and Christodoulos Stefanadis


DOI: 10.2174/157016107781024091




The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies

, 5(3): 239 - 248

Martin Smollich and Pia Wulfing


DOI: 10.2174/157016107781024082




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science